SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027348
Filing Date
2024-11-20
Accepted
2024-11-20 16:20:04
Documents
1
Period of Report
2024-11-19

Document Format Files

Seq Description Document Type Size
1 form4-11202024_041101.html 4  
1 form4-11202024_041101.xml 4 3317
  Complete submission text file 0001415889-24-027348.txt   4720
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address
Mehra Anand (Reporting) CIK: 0001590102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 241480653